Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Oral bicalutamide is safe and effective for female hair loss.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

The new drug delivery system improves bicalutamide skin retention for better treatment of hair loss.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Flutamide rarely causes liver toxicity in prostate cancer patients.

LGD1069 effectively prevents breast tumors in mice without toxicity.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.